Quest Diagnostics Incorporated

DGX Healthcare Diagnostics & Research

Quest Diagnostics Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $11.0 billion, up 11.8% from fiscal 2024.

Revenue
+9.98%
EPS
+29.4%
Free cash flow
+6.21%
Total debt
−2.20%

Quarter to September 2026, against a year earlier

255.89 1.15 +0.45%
Market cap
$28.0B
P/E
25.0×
Fwd P/E
24.4×
Dividend yield
1.33%
F-score
8/9
Altman Z
3.15
Beneish M
−2.65
Dividend safety
85/100

Quest Diagnostics Incorporated 10-K filed Feb 20, 2025

Fiscal year 2024 · Period ended Dec 31, 2024 · Filed · accepted 4:30 PM ET · Document on sec.gov · Filing index

What changed

Item 7, Management’s Discussion and Analysis: no comparison — incorporated by reference